BI 14332 CL Powder
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 14332 CL Powder, covering 2014-08-08 to 2014-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 14332 CL Powder in Healthy Male Subjects [Phase 1]